About Aaron Missere

Aaron Missere is the CEO and founder of financial media company Departures Capital Inc. He is an avid and experienced investor, with a primary focus on the cannabis industry. In addition to being a featured contributor to StockNews.com and ETFDailyNews.com, he is an author for SmarterAnalyst.com. Aaron also currently hosts a weekly show on YouTube that recaps and explains the movement in the stock market, with a heavy emphasis on marijuana stocks.

Recent Articles By Aaron Missere

: TLRY |  News, Ratings, and Charts

Why are Shares of Tilray (TLRY) Up Over 30% in the Past Week?

Over the last week, shares of Tilray Inc. (TLRY) have jumped more than 30% from a 52-week low of $15.01, to over $20.
: OGI |  News, Ratings, and Charts

Why is OrganiGram (OGI) Surging 46% Today?

Shares of OrganiGram (OGI) are on fire today, up 46%, after the company reported fiscal first-quarter revenue that doubled, crushing Wall Street estimates. 
: ACB |  News, Ratings, and Charts

Why Did Shares of Aurora Cannabis Trade to a 52-week Low Today?

Shares of Aurora Cannabis (ACB) have been getting crushed recently as more and more downgrades have hit the company.
: APHA |  News, Ratings, and Charts

What to Expect From Aphria's (APHA) Upcoming Earnings Report

While most other stocks in the cannabis industry have been reporting losses each quarter, Aphria Inc. (APHA) has bucked the trend. 
: CTST |  News, Ratings, and Charts

CannTrust: A High Risk/Reward Investment

At its highest level back in 2019, the CannTrust’s stock soared to above $10 per share. After the fallout, the stock crashed to $0.75.
: ACB |  News, Ratings, and Charts

Why is Aurora Cannabis Selling One of its Greenhouses?

This week Aurora Cannabis announced that they would be selling one of their largest greenhouses.
: CRON |  News, Ratings, and Charts

Where are Shares of Cronos Group Headed in 2020?

Last week we saw cannabis stocks skyrocket on the last day of trading and many are wondering if this will be the start of a huge rally for the sector.
: GWPH |  News, Ratings, and Charts

What are Analysts Predicting for Shares of GW Pharmaceuticals in 2020

There are a total of 15 analysts that cover GW Pharmaceuticals as of December 24, 2019. Of those analysts 5 rate the company a “strong-buy,” and 10 rate it as a “buy.”
: HEXO |  News, Ratings, and Charts

Where are Shares of HEXO headed in 2020?

2019 was an extremely tough year for HEXO shareholders. The stock saw highs in April of over $8 only to see it trade currently under $2. 
: SNDL |  News, Ratings, and Charts

Is Sundial Growers Inc. (SNDL) Poised for an Explosive 2020?

Sundial Growers is a recent large-cap IPO in the cannabis sector.
Page generated in 0.0053 seconds.